![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review](https://www.resed.es/Documentos/ArticulosImg/924/07_rev_libran_ing_tab3.jpg)
Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review
![Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors | Neuropsychopharmacology Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors | Neuropsychopharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnpp.2016.38/MediaObjects/41386_2016_Article_BFnpp201638_Fig1_HTML.jpg)
Antidepressant-like Effects of Buprenorphine are Mediated by Kappa Opioid Receptors | Neuropsychopharmacology
![Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review](https://www.resed.es/Documentos/ArticulosImg/924/07_rev_libran_ing_tab2.jpg)
Peripheral acting Mu opioid receptor antagonists in the treatment of the opioid-induced constipation: review
![Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41380-018-0117-2/MediaObjects/41380_2018_117_Fig2_HTML.jpg)
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry
![Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149763419306323-gr4.jpg)
Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect
![Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41380-018-0117-2/MediaObjects/41380_2018_117_Fig3_HTML.jpg)
Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches | Molecular Psychiatry
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
![Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-B978012420118700010X-f10-01-9780124201187.jpg)
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
![Methylnaltrexone Mechanisms of Action and Effects on Opioid Bowel Dysfunction and Other Opioid Adverse Effects - Chun-Su Yuan, 2007 Methylnaltrexone Mechanisms of Action and Effects on Opioid Bowel Dysfunction and Other Opioid Adverse Effects - Chun-Su Yuan, 2007](https://journals.sagepub.com/cms/10.1345/aph.1K009/asset/images/large/10.1345_aph.1k009-fig4.jpeg)
Methylnaltrexone Mechanisms of Action and Effects on Opioid Bowel Dysfunction and Other Opioid Adverse Effects - Chun-Su Yuan, 2007
![PDF) Targeting opioid receptor signalling in depression: do we need selective kappa opioid receptor antagonists? PDF) Targeting opioid receptor signalling in depression: do we need selective kappa opioid receptor antagonists?](https://i1.rgstatic.net/publication/324621315_Targeting_opioid_receptor_signalling_in_depression_do_we_need_selective_kappa_opioid_receptor_antagonists/links/5ad961fcaca272fdaf820b7e/largepreview.png)
PDF) Targeting opioid receptor signalling in depression: do we need selective kappa opioid receptor antagonists?
![Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149763419306323-gr2.jpg)